Chemoprevention of esophageal cancer with esomeprazole and aspirin therapy: Efficacy and safety in the phase III randomized factorial ASPECT trial.
Janusz Jankowski(University College London), Ian Penman(Edinburgh Royal Infirmary), Yeng Ang(The University of Texas MD Anderson Cancer Center), John de Caestecker(University Hospitals of Leicester NHS Trust), Rebecca Harrison(University Hospitals of Leicester NHS Trust), Sharon Love(Nuffield Orthopaedic Centre), Emma Roffe(Takeda (United Kingdom)), Paul Moayyedi(McMaster University Medical Centre), Gavin Reilly(University of Oxford), Peter J. Watson(Kinston Medical Specialists), Pradeep Bhandari(Queen Alexandra Hospital), Colin Rodgers(Northern Health and Social Care Trust), Krish Ragunath(Nottingham University Hospitals NHS Trust), Claire Brooks(Cancer Research UK Technology), Danielle Morris(Lister Hospital), Stephen E. Attwood(Durham University), S. Sanders(University of Warwick), James Neale(Torbay and South Devon NHS Foundation Trust), Hugh Barr(Gloucestershire Hospitals NHS Foundation Trust), Arthur Tucker(Queen Mary University of London)
Cited by 2
Related Papers
Pan-cancer analysis of whole genomes
|Nature|2020|3.3k
British Society of Gastroenterology guidelines on the diagnosis and management of Barrett's oesophagus
|Gut|2013|1.3k
Colorectal polypectomy and endoscopic mucosal resection (EMR): European Society of Gastrointestinal Endoscopy (ESGE) Clinical Guideline
|Endoscopy|2017|1.1k
Esophageal eosinophilia with dysphagia
|Digestive Diseases and Sciences|1993|889